Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [619]

Molecular stratification of breast cancer: reaching the clinic

Prof Carlos Caldas - University of Cambridge, UK

Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )

Phase 1-2 results for oral proteasome inhibitor MLN9708 for multiple myeloma...

Dr Rafael Fonseca – Mayo Clinic, Arizona, USA

Phase 1-2 results for oral proteasome inhibitor MLN9708 for multiple myeloma (Spanish) ( Dr Rafael Fonseca – Mayo Clinic, Arizona, USA )

Effects of lapatinib and trastuzumab on progression free survival

Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA

Effects of lapatinib and trastuzumab on progression free survival ( Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA )

ASCO 2012: advances in high-risk prostate cancer; neoadjuvant abiraterone

Dr Chris Parker - Royal Marsden Cancer Centre, UK; Dr Mary-Ellen Taplin, Dana...

ASCO 2012: advances in high-risk prostate cancer; neoadjuvant abiraterone ( Dr Chris Parker - Royal Marsden Cancer Centre, UK; Dr Mary-Ellen Taplin, Dana-Farber Cancer Institute, USA )

ASCO 2012: Metastatic castration-resistant prostate cancer; abiraterone acetate...

Dr Chris Parker - Royal Marsden Cancer Centre, UK; Dr Karim Fizazi from...

ASCO 2012: Metastatic castration-resistant prostate cancer; abiraterone acetate COU-AA-302 study ( Dr Chris Parker - Royal Marsden Cancer Centre, UK; Dr Karim Fizazi from Institut Gustave Roussy, France )

ASCO 2012: Advances in pre-operative care in high-risk mCRCP

Dr Chris Parker - Royal Marsden Cancer Centre, UK; Prof Eleni Efstathiou - MD...

ASCO 2012: Advances in pre-operative care in high-risk mCRCP ( Dr Chris Parker - Royal Marsden Cancer Centre, UK; Prof Eleni Efstathiou - MD Anderson Cancer Centre, USA )

ASCO 2012: Advances in metastatic castration-resistant prostate cancer with...

Dr Karim Fizazi - Institut Gustave Roussy, France; Dr Oscar Goodman - Nevada...

ASCO 2012: Advances in metastatic castration-resistant prostate cancer with abiraterone ( Dr Karim Fizazi - Institut Gustave Roussy, France; Dr Oscar Goodman - Nevada Cancer Institute, USA )

Intermittent hormonal therapy versus continuous therapy for advanced prostate...

Dr Maha Hussain - University of Michigan, Ann Arbor, USA

Intermittent hormonal therapy versus continuous therapy for advanced prostate cancer ( Dr Maha Hussain - University of Michigan, Ann Arbor, USA )

Intermittent hormonal therapy less effective than continuous therapy when...

Dr Maha Hussain - University of Michigan, Ann Arbor, USA

Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer ( Dr Maha Hussain - University of Michigan, Ann Arbor, USA )

Highlights and goals of IMPAKT 2012

Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium

Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )

Endocrine therapy and endocrine resistant breast cancer

Prof Mitch Dowsett – The Institute for Cancer Research, London, UK

Endocrine therapy and endocrine resistant breast cancer ( Prof Mitch Dowsett – The Institute for Cancer Research, London, UK )

Targeting DNA damage response and repair excluding PARP for triple negative...

Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden

Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )

More from ecancer